Ciclosporin topical gel - Perioc

Drug Profile

Ciclosporin topical gel - Perioc

Latest Information Update: 21 Apr 2017

Price : $50

At a glance

  • Originator Perioc
  • Class Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Neuroprotectants
  • Mechanism of Action Cyclophilin inhibitors; Peptidylprolyl isomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Periodontitis

Most Recent Events

  • 01 Oct 2016 Perioc completes a phase II trial in Periodontitis (Adjunctive treatment) in Sweden (Topical)
  • 26 Jan 2015 Phase-II clinical trials in Periodontitis (Adjunctive treatment) in Sweden (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top